Target intelligence / Profile preview

Epidermal growth factor receptor substrate 15 (EPS15)

Target
EPS15
Molecular classification
Other (Endocytic adaptor/scaffold protein), Adaptor protein, EH (Eps15 homology) domain-containing protein
01

Overview

Epidermal growth factor receptor substrate 15 (EPS15) is a cytoplasmic protein that plays a critical role in receptor-mediated endocytosis, especially for receptors such as the epidermal growth factor receptor (EGFR)[5][1][3]. EPS15 is predominantly localized at clathrin-coated pits in the plasma membrane and interacts with adaptor proteins such as AP-2 and accessory proteins like epsin, functioning as a scaffolding protein essential for the assembly of the endocytic machinery[3][4][5]. Structurally, EPS15 has three N-terminal EH (Eps15 homology) domains, a coiled-coil domain mediating dimerization and protein interactions, and C-terminal regions with multiple DPF motifs which mediate interactions with α-adaptin (AP-2 complex)[3][4]. EPS15 is phosphorylated by activated EGFR and cycles through different stages of the endocytic pathway, contributing to the internalization and trafficking of engaged receptors[1][3][4]. Disruption of its function impairs endocytosis of EGF and transferrin receptors[3]. In disease, chromosomal rearrangements involving EPS15 (notably with the HRX/ALL/MLL gene) have been identified in acute myelogenous leukemia, highlighting a role in oncogenesis[5][3]. EPS15 is not a classical receptor, enzyme, or ion channel, but rather a key adaptor in the molecular machinery underlying endocytosis and signal regulation. No known clinical drugs directly target EPS15, but its role in cell proliferation and endocytosis implicates it in cancer biology and intracellular trafficking disorders[3][5].

Other names
AF-1PMLLT5Protein AF-1pALL1 fused gene from chromosome 1protein AF-1pEps15AF1PEpidermal growth factor pathway substrate 15
02

Biological functions

Receptor-mediated endocytosisSignal transductionRegulation of intracellular traffickingClathrin-mediated endocytosisCell proliferation
03

Disease associations

CancerAcute myelogenous leukemiaPotential roles in other neoplastic processes
04

Safety considerations

Limited; potential implication in cell proliferation and transformation in neoplasia if targeted by future therapeutics (based on oncogenic fusion events)
05

Biomarkers

Rearrangement with MLL/HRX/ALL1 gene in acute myelogenous leukemia

Beyond the preview

Go deeper on Epidermal growth factor receptor substrate 15 (EPS15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epidermal growth factor receptor substrate 15 (EPS15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call